![Penny S. Toren](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
Penny S.
Toren worked as a Senior VP-Regulatory Affairs & Program Management at Vallon Pharmaceuticals, Inc. from 2018 to 2022.
She completed her undergraduate degree at Florida Atlantic University and her graduate degree at New York Medical College.
Antiguos cargos conocidos de Penny S. Toren.
Empresas | Cargo | Fin |
---|---|---|
GRI BIOPAR | Consejero General | 19/04/2022 |
Formación de Penny S. Toren.
Florida Atlantic University | Undergraduate Degree |
New York Medical College | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Vallon Pharmaceuticals, Inc.
![]() Vallon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vallon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on the development and commercialization of proprietary biopharmaceutical products. The firm's primary product is Abuse-Deterrent Amphetamine Immediate and its product pipeline includes ADAIR, ADMIR, ADHD, and Narcolepsy. The company was founded by David C. Baker on January 11, 2018 and is headquartered in Philadelphia, PA. | Health Technology |
- Bolsa de valores
- Insiders
- Penny S. Toren